| #23 |
Stuart Cockerill |
Reviral Limited |
1 |
| #23 |
Mike Trower |
Kandy Therapeutics Limited |
1 |
| #23 |
Gabor Pap |
GE |
1 |
| #23 |
Sarah Mary VALLANCE |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #23 |
Alexander G. Preston |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #23 |
Ekaterini Kotsopoulou |
Autolus Limited |
1 |
| #23 |
Caroline Dimech |
Glaxo Group Limited |
1 |
| #23 |
Alexander Walker Wishart |
Matra Marconi Space Uk Limited |
1 |
| #23 |
Sebastien Vavassori |
Airbus Defence And Space Gmbh |
1 |
| #23 |
Veronique Birault |
Glaxo Group Limited |
1 |
| #23 |
Derek William Judd |
Xerox |
1 |
| #23 |
Michael Trower |
E.I. Du Pont De Nemours And |
1 |
| #23 |
James Bailey |
Glaxosmithkline |
1 |
| #23 |
Colin F. Spraggs |
Novartis Ag |
1 |
| #23 |
Ann Louise Walker |
Glaxo Group Limited |
1 |
| #23 |
Martyn Deal |
— |
1 |
| #23 |
Claire Frances Crawford |
Glaxo Group Limited |
1 |
| #23 |
Paul Thomas McMahon |
Astrium Gmbh |
1 |
| #23 |
Giampietro Ventresca |
Glaxosmithkline |
1 |
| #23 |
Simon Leigh |
Airbus Defence And Space Gmbh |
1 |
| #23 |
Emiliangelo Ratti |
Glaxo Wellcome S.A. |
1 |
| #23 |
Emmanuel Hubert Demont |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #23 |
Myles Edward Richard Spence |
Seagate Technology |
1 |
| #23 |
John Liddle |
Glaxo Group Limited |
1 |